A Phase II Multicenter, Open-Label Study of YM155 in Ref

Project: Research project

Project Details

Description

A Phase II Multicenter, Open-Label Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects
StatusFinished
Effective start/end date2/8/075/31/10

Funding

  • Astellas Pharma US, Inc.